NICE center-stage again… but of what?
This article was originally published in Scrip
Executive Summary
The UK's National Institute for Health and Clinical Excellence (NICE) will retain its pre-eminence in the future drug assessments in the UK once a new pricing system is introduced, although the Department of Health continues to drag its feet on defining exactly how drugs will be priced after 2013.